These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26553011)

  • 1. Increased Prevalence of Controlled Viremia and Decreased Rates of HIV Drug Resistance Among HIV-Positive People Who Use Illicit Drugs During a Community-wide Treatment-as-Prevention Initiative.
    Milloy MJ; Wood E; Kerr T; Hogg B; Guillemi S; Harrigan PR; Montaner J
    Clin Infect Dis; 2016 Mar; 62(5):640-7. PubMed ID: 26553011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvements in HIV treatment outcomes among indigenous and non-indigenous people who use illicit drugs in a Canadian setting.
    Milloy MJ; King A; Kerr T; Adams E; Samji H; Guillemi S; Wood E; Montaner J
    J Int AIDS Soc; 2016; 19(1):20617. PubMed ID: 27094914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-intensity cannabis use and HIV clinical outcomes among HIV-positive people who use illicit drugs in Vancouver, Canada.
    Lake S; Kerr T; Capler R; Shoveller J; Montaner J; Milloy MJ
    Int J Drug Policy; 2017 Apr; 42():63-70. PubMed ID: 28336000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-response relationship between methadone dose and adherence to antiretroviral therapy among HIV-positive people who use illicit opioids.
    Lappalainen L; Nolan S; Dobrer S; Puscas C; Montaner J; Ahamad K; Dong H; Kerr T; Wood E; Milloy MJ
    Addiction; 2015 Aug; 110(8):1330-9. PubMed ID: 25940906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance use patterns and HIV-1 RNA viral load rebound among HIV-positive illicit drug users in a Canadian setting.
    Ladak F; Socias E; Nolan S; Dong H; Kerr T; Wood E; Montaner J; Milloy MJ
    Antivir Ther; 2019; 24(1):19-25. PubMed ID: 30230474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detectable Viral Load in Late Pregnancy among Women in the Rwanda Option B+ PMTCT Program: Enrollment Results from the Kabeho Study.
    Gill MM; Hoffman HJ; Bobrow EA; Mugwaneza P; Ndatimana D; Ndayisaba GF; Baribwira C; Guay L; Asiimwe A
    PLoS One; 2016; 11(12):e0168671. PubMed ID: 28006001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Correlates of Reporting Difficulty Taking Antiretroviral Treatment Among HIV-Positive Illicit Drug Users in Vancouver, Canada: A Longitudinal Analysis.
    Yeung B; Mohd Salleh NA; Socías E; Dong H; Shoveller J; Montaner JSG; Milloy MS
    AIDS Behav; 2019 May; 23(5):1250-1257. PubMed ID: 30284081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social and structural factors associated with greater time with a plasma HIV-1 RNA viral load above log10(1500) copies/ml among illicit drug users.
    Kennedy MC; Kerr TH; Wood E; Shoveller JA; Montaner JSG; Milloy MS
    AIDS; 2018 May; 32(8):1059-1067. PubMed ID: 29424782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increases in CD4
    Tran M; Wood E; Kerr T; Patterson S; Bangsberg D; Dong H; Guillemi S; Montaner JS; Milloy MJ
    Antivir Ther; 2017; 22(5):403-411. PubMed ID: 28234234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of engagement in an HIV/AIDS integrated health programme on plasma HIV-1 RNA suppression among HIV-positive people who use illicit drugs: a marginal structural modelling analysis.
    Ti L; Dong H; Kerr T; Turje RB; Parashar S; Min JE; Montaner J; Wood E; Milloy MJ
    HIV Med; 2017 Sep; 18(8):580-586. PubMed ID: 28317290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longer duration of homelessness is associated with a lower likelihood of non-detectable plasma HIV-1 RNA viral load among people who use illicit drugs in a Canadian setting.
    Loh J; Kennedy MC; Wood E; Kerr T; Marshall B; Parashar S; Montaner J; Milloy MJ
    AIDS Care; 2016 Nov; 28(11):1448-54. PubMed ID: 27248328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trajectory analyses of virologic outcomes reflecting community-based HIV treatment in Washington DC 1994-2012.
    Ocampo JM; Plankey M; Zou K; Collmann J; Wang C; Young MA; Liu C; Ripple JA; Kassaye S
    BMC Public Health; 2015 Dec; 15():1277. PubMed ID: 26695971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa.
    Boender TS; Hoenderboom BM; Sigaloff KC; Hamers RL; Wellington M; Shamu T; Siwale M; Labib Maksimos EE; Nankya I; Kityo CM; Adeyemo TA; Akanmu AS; Mandaliya K; Botes ME; Ondoa P; Rinke de Wit TF
    Clin Infect Dis; 2015 Dec; 61(11):1749-58. PubMed ID: 26240203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community viral load, antiretroviral therapy coverage, and HIV incidence in India: a cross-sectional, comparative study.
    Solomon SS; Mehta SH; McFall AM; Srikrishnan AK; Saravanan S; Laeyendecker O; Balakrishnan P; Celentano DD; Solomon S; Lucas GM
    Lancet HIV; 2016 Apr; 3(4):e183-90. PubMed ID: 27036994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residential Eviction and Risk of Detectable Plasma HIV-1 RNA Viral Load Among HIV-Positive People Who Use Drugs.
    Kennedy MC; Kerr T; McNeil R; Parashar S; Montaner J; Wood E; Milloy MJ
    AIDS Behav; 2017 Mar; 21(3):678-687. PubMed ID: 26906022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suboptimal plasma HIV-1 RNA suppression and adherence among sex workers who use illicit drugs in a Canadian setting: an observational cohort study.
    Ti L; Milloy MJ; Shannon K; Simo A; Hogg RS; Guillemi S; Montaner J; Kerr T; Wood E
    Sex Transm Infect; 2014 Aug; 90(5):418-22. PubMed ID: 24523347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dispensation of antiretroviral therapy and methadone maintenance therapy at the same facility in a low-barrier setting linked to optimal adherence to HIV treatment.
    Mohd Salleh NA; Fairbairn N; Nolan S; Barrios R; Shoveller J; Richardson L; Milloy MJ
    HIV Med; 2019 Oct; 20(9):606-614. PubMed ID: 31359615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Criminal Justice System Involvement as a Risk Factor for Detectable Plasma HIV Viral Load in People Who Use Illicit Drugs: A Longitudinal Cohort Study.
    Ickowicz S; Salleh NAM; Fairbairn N; Richardson L; Small W; Milloy MJ
    AIDS Behav; 2019 Sep; 23(9):2634-2639. PubMed ID: 31236749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation.
    Laprise C; de Pokomandy A; Baril JG; Dufresne S; Trottier H
    Clin Infect Dis; 2013 Nov; 57(10):1489-96. PubMed ID: 23946221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Socioeconomic marginalization and plasma HIV-1 RNA nondetectability among individuals who use illicit drugs in a Canadian setting.
    Richardson LA; Kerr TH; Dobrer S; Puskas CM; Guillemi SA; Montaner JS; Wood E; Milloy MJ
    AIDS; 2015 Nov; 29(18):2487-95. PubMed ID: 26558546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.